InMode slips after board committee rejects deal proposals
** U.S.-listed shares of Israel-based medical technology firm InMode INMD.O fall 6% to $14.30 premarket ** INMD says a special committee of its board reviewed possible deal proposals but found none good enough ** The company says the committee has ended the process and will keep reviewing its business plans and use of cash ** Last month, Steel Partners offered $18 per share to acquire a 51% stake in InMode ** Earlier this month, co said it was evaluating potential strategic alternatives ** INMD fell 12% in 2025 (Reporting by Kamal Choudhury in Bengaluru) ((Kamal.Choudhury@thomsonreuters.com;))
Recent news on InMode
See all newsBrief: Inmode Haifa District Court Denied Sp Strategic Holdings' Request For Temporary Injunctive Relief In Its Entirety
InMode Ltd. reports results for the quarter ended June 30 - Earnings Summary
Brief: Inmode Q2 Revenue USD 95.589 Million Versus. Ibes Estimate USD 93 Million
InMode Q2 revenue beats estimates on steady U.S. demand
Brief: Steel Partners Urges Inmode Shareholders To Vote Against The Re-Election Of Dr. Hadar Ron And Against Extraordinary Special Committee Compensation At The July 30 Annual General Meeting